US Bancorp’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $333K | Sell |
|
|||||
|
2025
Q1 | $459K | Buy |
|
|||||
|
2024
Q4 | $409K | Sell |
|
|||||
|
2024
Q3 | $519K | Sell |
|
|||||
|
2024
Q2 | $966K | Buy |
|
|||||
|
2024
Q1 | $1.02M | Sell |
|
|||||
|
2023
Q4 | $1.37M | Sell |
|
|||||
|
2023
Q3 | $4.06M | Buy |
|
|||||
|
2023
Q2 | $1.64M | Sell |
|
|||||
|
2023
Q1 | $2.59M | Sell |
|
|||||
|
2022
Q4 | $2.76M | Buy |
|
|||||
|
2022
Q3 | $1.95M | Sell |
|
|||||
|
2022
Q2 | $1.96M | Sell |
|
|||||
|
2022
Q1 | $2.28M | Buy |
|
|||||
|
2021
Q4 | $2.44M | Buy |
|
|||||
|
2021
Q3 | $1.94M | Sell |
|
|||||
|
2021
Q2 | $2.1M | Sell |
|
|||||
|
2021
Q1 | $2.12M | Sell |
|
|||||
|
2020
Q4 | $4.79M | Buy |
|
|||||
|
2020
Q3 | $3.36M | Sell |
|
|||||
|
2020
Q2 | $5.56M | Buy |
|
|||||
|
2020
Q1 | $3.63M | Buy |
|
|||||
|
2019
Q4 | $3.57M | Buy |
|
|||||
|
2019
Q3 | $925K | Buy |
|
|||||
|
2019
Q2 | $785K | Sell |
|
|||||
|
2019
Q1 | $905K | Buy |
|
|||||
|
2018
Q4 | $860K | Sell |
|
|||||
|
2018
Q3 | $993K | Sell |
|
|||||
|
2018
Q2 | $1.02M | Buy |
|
|||||
|
2018
Q1 | $833K | Buy |
|
|||||
|
2017
Q4 | $915K | Buy |
|
|||||
|
2017
Q3 | $931K | Buy |
|
|||||
|
2017
Q2 | $730K | Buy |
|
|||||
|
2017
Q1 | $688K | Sell |
|
|||||
|
2016
Q4 | $658K | Buy |
|
|||||
|
2016
Q3 | $611K | Buy |
|
|||||
|
2016
Q2 | $482K | Sell |
|
|||||
|
2016
Q1 | $553K | Buy |
|
|||||
|
2015
Q4 | $595K | Buy |
|
|||||
|
2015
Q3 | $553K | Buy |
|
|||||
|
2015
Q2 | $632K | Buy |
|
|||||
|
2015
Q1 | $414K | Buy |
|
|||||
|
2014
Q4 | $230K | Buy |
|
|||||
|
2014
Q3 | $141K | Sell |
|
|||||
|
2014
Q2 | $162K | Buy |
|
|||||
|
2014
Q1 | $153K | Buy |
|
|||||
|
2013
Q4 | $143K | Sell |
|
|||||
|
2013
Q3 | $297K | Buy |
|
|||||
|
2013
Q2 | $79K | Buy |
|